Artra Group Corporation

6029.T
Medical Care Facilities
2026/10/28 18:47 Updated
Market Cap: $12.3M (¥1.9B)
Stock Price: $1.17 (¥185)
Exchange Rate: 1 USD = ¥157.98

Notice Regarding Establishment of SIbot Co., Ltd. and Commencement of New Business

Resolved to establish the joint venture SIbot Co., Ltd. Capital composition: Artra Group Corporation 51.0%, RBB Co., Ltd. 49.0%. The new company will handle sales and implementation support for humanoid robots and operate a data factory. Commencement is planned within 2026, with approximately 150 million yen of total investment funded from internal resources. Contribution to consolidated net sales is expected from fiscal 2027 onward, but due to depreciation and other initial expenses, the impact in the first year is uncertain.

Importance:
Page Updated: October 29, 2026
IR Disclosure Date: October 29, 2026

Key Figures

  • New company capital 1,000 thousand yen
  • New company establishment date 2026-10-31 (planned)
  • Planned new capital investment 100 million yen (data factory related) + interior construction and other costs 50 million yen, total approx. 150 million yen

AI要約

Overview of Newly Established Joint Venture

The Company will establish SIbot Co., Ltd. through joint capital investment with RBB Co., Ltd., to engage in sales and implementation support for humanoid robots. The company will establish and operate a data factory (training center) and aim to apply accumulated training data to the medical and nursing care fields. The new company is scheduled to become a consolidated subsidiary of the Company. Capital ratio: Artra Group Corporation 51.0%, RBB Co., Ltd. 49.0%.

Future Outlook and Impact

The establishment of the new company is expected to have a minor impact on consolidated results for the fiscal year ending December 2026, but is expected to contribute to improved performance and corporate value over the long term. While consolidated net sales growth is anticipated from the fiscal year ending December 2027 onward, initial depreciation and other expenses are expected, and the impact amount for the fiscal year ending December 2027 is not definitive. Funding will be covered by internal funds.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Artra Group Corporation

Company overview · Stock price · Financial data · All IR

View company page →